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COVID-19
Nearly every country is now affected by the coronavirus disease 2019 
(COVID-19) pandemic. The disease is spreading rapidly and is taxing the 
global healthcare system, particularly intensive care units (ICUs). 
Physicians are faced with ethical decisions regarding the allocation of 
these precious resources, especially ventilators. Although only a few of 
those infected with severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) require admission to intensive care, the burden on 
healthcare systems is unprecedented. This article focuses on ethical 
issues in decision-making regarding COVID-19, particularly in the 
elderly. 
Madrid has been one of the cities with the higher number of COVID-19 
cases and casualties so far. We have suffered from limited resources 
and lived with these ethical issues on a daily basis. Also, Spain is 
experiencing population ageing at a rate that is unprecedented in 
Europe and COVID-19 infection is particularly severe in the elderly.1,2
Prioritisation
Prioritisation for the allocation of scarce resources is not confined to 
the COVID-19 outbreak. Transplant organs are examples of scarce 
resources where prioritisation criteria for allocation are common and 
physicians have to make a case-by-case evaluation in order to 
establish which patient receives the organ. Prioritisation reflects 
established practices that regulate the distribution of finite resources 
when demand happens to exceed supply. Discrimination based on 
sex, race or age has no role in prioritisation unless clearly justified, for 
example sex mismatch might influence the outcome of a heart 
transplant.3,4 
Prioritisation does not mean that one life is more valuable than another, 
as all lives are equally valuable. When resources are insufficient to save 
all those in need, prioritisation means allocating the available assets in 
the most effective way. This method allows priority treatment of 
patients more likely to benefit from the scarce resource. Prioritisation 
should be as objective as possible but also flexible to changes in clinical 
situation. Transparent mechanisms to determine which patients will 
receive a specific resource are desirable and should be explained to 
patients who finally receive an organ, to those who are denied and to 
the public.
Ageism
Ageism encompasses stereotyping, prejudice and discrimination 
against people on the basis of their age. Ageism is widespread and an 
insidious practice that has harmful effects on the health of older adults. 
A recent systematic review showed that the significant adverse 
relationship between ageism and health is even more consistent than 
the relationships found in systematic reviews of the effects of racism 
on health.5 Moreover, European doctors worry about the care they will 
receive when they are old, with 80% of healthcare professionals 
anxious about how they would be treated, suggesting they realise that 
ageism is very common.6 Paradoxically, increasing numbers of elderly 
people are remaining healthy and some of them have important 
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international responsibilities. For instance, Pope Francis is now 83 
years old and Queen Elizabeth II is 94 (Figure 1).
COVID-19 and the Elderly
The risk posed by COVID-19 is higher for elderly people than for younger 
people.2 For this reason, medical and political authorities should offer 
older adults strict preventive measures to minimise the risk of exposure 
and infection. In the event that an effective vaccine for SARS-CoV-2 is 
developed, priority should be given to vaccination of the elderly, with 
the aim of maximising the number of lives saved. This is also true for 
other preventive measures, such as possible pre- or post-exposure 
prophylaxis.7 
In the case of people with COVID-19, the situation is different. When 
allocating resources in these scenarios, healthcare professionals might 
prioritise those most likely to survive over those with remote chances 
of survival. Making a decision based on chronological age is not 
justified. In addition to age, other aspects that determine theoretical life 
expectancy must be taken into account. Biological age and the use of 
frailty scales and comprehensive geriatric assessment are essential for 
this purpose. The recent statement of the Executive Board of the 
European Geriatric Medicine Society insists that advanced age alone 
should not be a criterion for excluding patients from specialised 
hospital units.8 If an elderly patient is dismissed from a specialised 
hospital unit for any reason, access to medical attention, symptomatic 
treatment and palliative care must be ensured. This last point is 
essential, as palliative care is frequently suboptimal in elderly patients 
with other conditions, such as heart failure, and this is probably the 
case in COVID-19.2,9,10
Therapeutic Adaptation after COVID-19 Admission
In patients with advanced age who are admitted to hospital due to a 
severe SARS-CoV-2 infection, it is very important to establish a 
therapeutic adaptation plan from the time of admission. This plan 
should be clearly documented in the clinical history, making it clear 
whether or not the patient is a candidate for mechanical ventilation 
and, in case of their condition worsening, when to propose the 
withdrawal of life-sustaining therapies (Table 1). Decisions that 
maximise survival to hospital discharge, the number of years of life 
saved and the possibility of living each of the stages of life can be 
prioritised. In this regard, patients with minimal expected benefit 
should not be admitted to ICU and the admission of patients with a 
life expectancy <1–2 years should be carefully evaluated. This 
applies to patients of all ages. A utilitarian mentality should be 
applied, which should prevent prejudice against the elderly. For 
example, a frail elderly patient might have a low chance of surviving 
the prolonged intubation required to recover from COVID-19 
pneumonia, but this is also the case for young patients with severe 
comorbidities.11
The Madrid Experience
During the peak of the outbreak, more than two-thirds of beds in most 
hospitals in Madrid were occupied by patients with COVID-19. Figure 2 
depicts the official numbers of patients admitted to hospital, admitted 
to ICUs, who died and who recovered in Spain between mid-March 
and the middle of April.12 Non-invasive ventilation was attempted 
frequently, even using improvised alternative strategies like the 
modified Easybreath diving mask to administer continuous positive 
Figure 1: Queen Elizabeth II and Pope Francis
Queen Elizabeth II, aged 94, and Pope Frances, aged 83. Would they receive optimal management if they had severe COVID-19? Sources: Cubankite/Shutterstock.com and AM113/
Shutterstock.com.
Table 1. Therapeutic Planning Checklist for Elderly 
Patients Admitted to Hospital due to COVID-19
• Discuss the full therapeutic plan with the patient (and family members)
• Ask about advance directives
• Identify any next of kin who might be involved in end-of-life decisions
• Obtain relatives’ contact information (the more the better)
• Include the therapeutic plan clearly in the clinical history
• Assess and record whether or not the patient is a candidate for mechanical 
ventilation 
• Assess and record whether or not the patient is a candidate for 
cardiopulmonary resuscitation
• Discuss the possibility of future withdrawal of life-sustaining therapies 
• Ask about religion/spiritual preferences
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airway pressure therapy. Invasive ventilation was often necessary and, 
in spite of tremendous efforts by the hospitals (for example Gregorio 
Marañón University Hospital opened ICUs in operating rooms and in 
the library), there were not enough ICU beds for all the critically ill 
patients who needed them. The limited availability of ventilation 
support was even more problematic due to the prolonged intubation – 
often more than 3 weeks – that many of these patients required. The 
news that prioritisation criteria were being applied in Spanish hospitals 
sparked widespread controversy and triggered a debate about the 
right of every individual, particularly the elderly, to access specialised 
healthcare.13 
Use of Off-label Therapies
Effective therapies for this novel coronavirus are needed urgently 
and several clinical trials are now underway.14 Meanwhile, the use of 
use of off-label therapies based on in vitro data and early clinical 
experience with COVID-19 has increased dramatically; examples 
include remdesivir, lopinavir, ritonavir, interferon, chloroquine, 
hydroxychloroquine, azithromycin, tocilizumab, steroids and 
cyclosporine. To date, no therapies have been shown to be 
effective.15 Moreover, some of these drugs have frequent and 
potentially life-threatening side-effects, particularly in the elderly. 
Most are known to prolong the QT interval and can have a 
proarrhythmic effect.16
Confinement: Pros and Cons 
Confinement is an effective way to decrease SARS-CoV-2 transmission 
and is a way to win time until effective therapies are developed and/or 
an effective and safe vaccine is available. However, the stay-at-home 
policy has negative effects in those with advanced age (Figure 3). The 
psychological risk of confinement is particularly high among vulnerable 
populations, such as those in a situation of dependence or that live 
alone. The negative consequences are multifaceted, with physical, 
mental and social aspects. Staying at home for long periods of time 
facilitates sedentary behaviours and might worsen previous frailty or 
pre-frail conditions. At the time of writing this article, our parents/
grandparents (aged 82 and 78) have not left their home for 2 months. 
We are certainly concerned about their situation. Moreover, 
confinement is extremely negative for the economy and the elderly 
might end up suffering the consequences of a severe economic 
depression. Finally, the legal situation varies a lot from country to 
country. New laws have created legal frameworks that frequently 
restrict or prohibit the movement of people and vehicles. Some 
countries have severe penalties for those who do not comply with the 
new rules.
Family and Mourning
The COVID-19 pandemic has isolated the elderly not only at home but 
also in hospitals. Visits are usually not permitted. Several patients of 
advanced age with severe infection have died alone in the hospital or 
in nursing homes. 
The suffering of the family does not end there, as containment 
measures also apply in the context of mourning, which adds trauma 
to that of death itself. Corpses are considered potentially infectious, 
so are deposited as soon as possible in a body bag that will never be 
reopened. During the peak of the outbreak in Madrid, we had so many 
deaths that an ice rink had to be used as a provisional morgue. It was 
frequently impossible for families to see their deceased loved ones 
one last time. 
The rules of social distancing put in place by the health authorities 
applies also at funerals. Services must be limited to close family 
members only (with a maximum of three people), usually with video 
recording and streaming for those who wish to attend the funeral from 
a distance. Finally, the vast majority of older people in Spain are Catholic. 
The fact that public masses have been cancelled makes the situation 
even more difficult for families. 
Conclusion
COVID-19 in elderly patients raises some ethical issues; however, most 
of these issues are similar to ethical problems in other conditions, 
such as heart failure.17–19 The correct prioritisation for the allocation of 
scarce resources should be based on various factors relating to the 
individual. Chronological age should not be the only factor that 
influences the decision-making process. This is essential to good 
clinical practice. 
Figure 2: Official Daily Evolution of the Number of 
Patients Admitted to Hospital, Admitted to Intensive 
Care Units, who Died and who Recovered in Spain
Source: Ministerio de Sanidad et al. 2020.12
Figure 3: Confinement – the Stay-at-home Policy – has 
Positive and Negative Effects in Individuals of Advanced Age
Cons Pros
Physical and
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